We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Transforming Cancer Drug Discovery With Comprehensive Tumor Models

Blue "MIMETAS" logo is positioned in the bottom left. Black background with abstract, colorful patterns resembling microscopic cells.

Cancer remains a global challenge, demanding innovative solutions.

Traditional in vivo animal models and 2D in vitro models often fail to replicate the complexities of the human tumor microenvironment (TME), leading to high attrition rates of novel drugs tested in clinical trials.

This whitepaper explores advanced organ-on-a-chip technology and 3D tissue modeling that is closing the translational gap in cancer drug discovery. 

Download this whitepaper to uncover:

  • Insights from six oncology applications of 3D tumor models, including immune cell migration and CAR T cell therapy development
  • How to gain quantifiable results for informed decision-making
  • The benefits of a strategic partnership in accelerating new cancer treatment discoveries 
Brought to you by
Download Your Whitepaper for FREE Below
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.